S&P 5007,489.72▲0.7% Nasdaq25,373.85▲1.0% Dow52,485.03▲0.5% Russell 2K2,931.34▼0.5% 10-Yr4.75%+8bp VIX15.99−1.10 WTI$86.80▲3.8% Gold$4,098.60▼0.0% EUR/USD1.153▲0.5% BTC$63,009▲0.3% Nikkei61,867▲0.7%
At close · Fri, Jul 31, 2026
Daily Market Updates.

US Markets

Home›US Markets›Sectors›Retail pharmacies positioned as weight-loss drug acces…

Retail pharmacies positioned as weight-loss drug access trend accelerates

CNBC Markets says the shift to direct prescription access for GLP-1 weight-loss drugs could boost demand for major retail pharmacy operators like Walmart, Costco, and Amazon.

Reported · Written up by our desk · Sectors

CNBC Markets reports that as Americans increasingly move toward direct access to GLP-1 prescriptions for weight loss, retail pharmacy chains are positioned to benefit from the trend.

The outlet points to large retail operators, including Walmart, Costco, and Amazon, as potential winners as consumers seek easier pathways to obtain these medications through retail channels.

← Newer storyJapan ends rescue at quake-hit Aeon shopping centre after 7 deaths

More like this

US MarketsHigh car-loan payments are rising, hitting both new and used buyers
US MarketsTrump Media launches paid data service for faster access to Truth Social posts
US MarketsUber and Waymo clash over mass AV plans in Washington, D.C.
US MarketsRay Dalio says cash is the worst long-term asset as inflation erodes value
US MarketsWall Street strategists weigh whether the stock selloff is ending

Sources

CNBC MarketsAs Americans go direct with GLP-1 prescriptions, Walmart, Costco, Amazon will be big weight-loss winners

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.